Ask the Scholar

Page 4 of 6
I can add historical knowledge about this page.

Page image

Page 4

OCR

- 3 - vaccine invested large sums of money to insure that sizeable amounts of the vaccine would be available before the full impact of this year's polio season was felt. The dramatic publicity accompanying the report of the vaccine's efficacy has aroused an enormous amount of public interest. The supply of vaccine on hand now or likely to become available during the next few months is far short of the needs and demands. The theory exists in some quarters that sizeable amounts of vaccine may appear in black markets, that prices may rise beyond reason, and that, as a consequence, many individuals in the most susceptible age groups will not receive the preventive. Concern over these possibilities has been ex- pressed by individual members of the Congress, and legislation has already been proposed which would require that the Federal Government supervise distribution of the vaccine. These, as I have said, are the basic facts. Without attempting to suggest a formal agenda, may I say that in my opinion there are two major questions which require the most careful kind of study. First and foremost is the question of supply. I think it is fair to say that very great misapprehension exists at the present time concern- ing this central fact -- how soon, within the understandable limits of productive capacity, will there be sufficient supplies of vaccine to take care of the children of America. Second, there is the question of distribu- tion -- what steps are necessary to assure that vaccine on hand goes first to the most susceptible age groups in the population. We know that we can expect all pertinent data from this group with respect to the first question, and your thoughtful consideration in an attempt to find the answer to the second one.

Page data

Page
4
Source index
0
Type
photo
Media ID
8db70be95deb253f
Size
unknown

Document data

ID
12166301
Core
doc
Type
document
DTO data
{
    "id": "12166301",
    "sourceUrl": "https://catalog.archives.gov/id/12166301",
    "contentType": "document",
    "title": "Remarks by Oveta Culp Hobby, Secretary of Health, Education, and Welfare, Given at a Conference on the Salk Polio Vaccine",
    "citationUrl": "https://catalog.archives.gov/id/12166301",
    "collections": [
        "Oveta Culp Hobby Papers",
        "Personal Files"
    ],
    "iiifBase": "https://s3.amazonaws.com/NARAprodstorage/lz/presidential-libraries/eisenhower/582312/582312_001_Page_1.jpg",
    "thumbnailUrl": "https://s3.amazonaws.com/NARAprodstorage/lz/presidential-libraries/eisenhower/582312/582312_001_Page_1.jpg",
    "largeImageUrl": "https://s3.amazonaws.com/NARAprodstorage/lz/presidential-libraries/eisenhower/582312/582312_001_Page_1.jpg",
    "imageCount": 6,
    "hasImages": true,
    "source": "import",
    "hasTranscription": false
}

Context sent to Scholar

Document identity
{
    "localId": "12166301",
    "label": "Remarks by Oveta Culp Hobby, Secretary of Health, Education, and Welfare, Given at a Conference on the Salk Polio Vaccine",
    "core": "doc",
    "dtoType": "document",
    "citationUrl": "https://catalog.archives.gov/id/12166301"
}
Document source metadata
{
    "id": "12166301",
    "sourceUrl": "https://catalog.archives.gov/id/12166301",
    "contentType": "document",
    "title": "Remarks by Oveta Culp Hobby, Secretary of Health, Education, and Welfare, Given at a Conference on the Salk Polio Vaccine",
    "citationUrl": "https://catalog.archives.gov/id/12166301",
    "collections": [
        "Oveta Culp Hobby Papers",
        "Personal Files"
    ],
    "iiifBase": "https://s3.amazonaws.com/NARAprodstorage/lz/presidential-libraries/eisenhower/582312/582312_001_Page_1.jpg",
    "thumbnailUrl": "https://s3.amazonaws.com/NARAprodstorage/lz/presidential-libraries/eisenhower/582312/582312_001_Page_1.jpg",
    "largeImageUrl": "https://s3.amazonaws.com/NARAprodstorage/lz/presidential-libraries/eisenhower/582312/582312_001_Page_1.jpg",
    "imageCount": 6,
    "hasImages": true,
    "source": "import",
    "hasTranscription": false
}
Document source extras
{
    "url": "https://catalog.archives.gov/id/12166301",
    "naId": 12166301,
    "levelOfDescription": "item",
    "productionDates": [
        {
            "day": 22,
            "logicalDate": "1955-04-22",
            "month": 4,
            "year": 1955
        }
    ],
    "recordType": "description",
    "ocrSource": "nara-archive"
}
Page context
{
    "seq": 4,
    "pageIndex": 0,
    "type": "photo",
    "url": "https://s3.amazonaws.com/NARAprodstorage/lz/presidential-libraries/eisenhower/582312/582312_001_Page_4.jpg",
    "mediaId": "8db70be95deb253f",
    "ocrText": "- 3 -\nvaccine invested large sums of money to insure that sizeable amounts of\nthe vaccine would be available before the full impact of this year's polio\nseason was felt.\nThe dramatic publicity accompanying the report of the vaccine's\nefficacy has aroused an enormous amount of public interest.\nThe supply of vaccine on hand now or likely to become available\nduring the next few months is far short of the needs and demands. The\ntheory exists in some quarters that sizeable amounts of vaccine may appear\nin black markets, that prices may rise beyond reason, and that, as a\nconsequence, many individuals in the most susceptible age groups will not\nreceive the preventive. Concern over these possibilities has been ex-\npressed by individual members of the Congress, and legislation has already\nbeen proposed which would require that the Federal Government supervise\ndistribution of the vaccine.\nThese, as I have said, are the basic facts.\nWithout attempting to suggest a formal agenda, may I say that in\nmy opinion there are two major questions which require the most careful\nkind of study.\nFirst and foremost is the question of supply. I think it is fair\nto say that very great misapprehension exists at the present time concern-\ning this central fact -- how soon, within the understandable limits of\nproductive capacity, will there be sufficient supplies of vaccine to take\ncare of the children of America. Second, there is the question of distribu-\ntion -- what steps are necessary to assure that vaccine on hand goes first\nto the most susceptible age groups in the population.\nWe know that we can expect all pertinent data from this group with\nrespect to the first question, and your thoughtful consideration in an\nattempt to find the answer to the second one."
}